Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 66.00
0.00 (0.00%)
May 6, 2026, 8:00 AM GMT
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 24.92 million as of May 6, 2026. Its market cap has increased by 73.68% in one year.
Market Cap
24.92M
Enterprise Value
18.89M
Revenue
1.71M
Ranking
n/a
PE Ratio
27.93
Stock Price
66.00
Market Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 24.92M, a decrease of -62.80%. That is a compound annual growth rate of -18.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 24.92M | -18.01% |
| Dec 31, 2025 | 30.39M | 9.52% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | 66.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| hVIVO | 50.15M |
| Hemogenyx Pharmaceuticals | 43.47M |
| Poolbeg Pharma | 30.32M |
| Sareum Holdings | 27.96M |
| ImmuPharma | 25.83M |
| SkinBioTherapeutics | 25.27M |
| Aptamer Group | 21.59M |
| Fusion Antibodies | 17.50M |